Middleton & Co’s Eli Lilly LLY Stock Holding History

Middleton & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.6M	Buy	13,020 +54	+0.4%	+$55.2K	1.66%	14
2026 Q1	$11.9M	Buy	12,966 +286	+2%	+$290K	1.36%	20
2025 Q4	$13.6M	Buy	12,680 +573	+5%	+$548K	1.45%	21
2025 Q3	$9.24M	Buy	12,107 +11,432	+1,694%	+$8.51M	1%	34
2025 Q2	$526K	Hold	675	–	–	0.06%	112
2025 Q1	$557K	Sell	675 -61	-8%	-$50.8K	0.07%	109
2024 Q4	$568K	Hold	736	–	–	0.06%	105
2024 Q3	$652K	Hold	736	–	–	0.07%	106
2024 Q2	$666K	Hold	736	–	–	0.08%	102
2024 Q1	$573K	Sell	736 -25	-3%	-$17.8K	0.07%	107
2023 Q4	$444K	Hold	761	–	–	0.06%	112
2023 Q3	$409K	Sell	761 -26	-3%	-$13.4K	0.06%	110
2023 Q2	$369K	Hold	787	–	–	0.05%	121
2023 Q1	$270K	Hold	787	–	–	0.04%	135
2022 Q4	$288K	Hold	787	–	–	0.04%	135
2022 Q3	$254K	Hold	787	–	–	0.04%	135
2022 Q2	$255K	Hold	787	–	–	0.03%	143
2022 Q1	$225K	Hold	787	–	–	0.02%	152
2021 Q4	$217K	Buy	+787	New	+$200K	0.02%	153

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Middleton & Co's LLY Position: Q2 2026 in Review

Middleton & Co increased its Eli Lilly (LLY) stake by 0.42% in Q2 2026, buying an estimated $55.2K and bringing the position to 13,020 shares worth $15.6M. The position accounts for 1.66% of the portfolio, ranked #14.

Middleton & Co first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Middleton & Co held 13,020 shares of Eli Lilly worth $15.6M as of Q2 2026.
Middleton & Co bought 54 Eli Lilly shares in Q2 2026, an estimated $55.2K.
Eli Lilly made up 1.66% of Middleton & Co's portfolio in Q2 2026, its #14 holding.
Middleton & Co first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Middleton & Co's 13F filing for Q2 2026, filed 10 Aug 2026.